SEP 02, 2019 12:47 PM PDT

Drug Reduces Heart Attacks in Diabetic Patients

WRITTEN BY: Nouran Amin

Recent results from a clinical trial that evaluated the addition of a drug called ‘ticagrelor’ to aspirin were shown to improve clinical outcomes for patients with stable coronary artery disease and diabetes mellitus. These patients in the study had no history of heart attack or stroke.

Findings from the clinical trial known as ‘The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS), explained how the usage of ticagrelor with aspirin formed a dual-antiplatelet therapy that has reduced the risk of cardiovascular death, heart attack, and stroke. However, the study did show that patients on the dual therapy also experienced a greater risk of a major bleed and intracranial hemorrhage, particularly through an increased number of non-procedural subdural bleeds, in comparison to those who were on the placebo.

"With prolonged dual-antiplatelet therapy, we need to be thoughtful in considering which patients are most suited to taking the regimen -- that is, those at high ischemic risk and low bleeding risk," said THEMIS co-chair Deepak L. Bhatt, MD, MPH, executive director of Interventional Cardiovascular Programs at the Brigham and professor of medicine at Harvard Medical School. "Our findings show that the greatest benefit occurred in those patients with diabetes and stable coronary artery disease with a history of prior stenting for whom ticagrelor, when added to aspirin, reduced important cardiovascular events, such as heart attacks, strokes and amputations."

THEMIS is the largest clinical trial study involving diabetic patients to date with more than 19,000 participants who have stable coronary artery disease and diabetes that were randomly selected to receive either ticagrelor plus aspirin (the dual antiplatelet therapy) or a placebo plus aspirin. These patients were studied over the course of three years

"The THEMIS population is a critically important one in which to understand the potential benefits of taking ticagrelor in addition to aspirin. As the number of people with diabetes continues to rise globally, we need to evaluate ways of improving long-term outcomes and preventing cardiovascular and ischemic events,” says THEMIS co-chair Philippe Gabriel Steg, MD, Chief of Cardiology at Hôpital Bichat, Greater Paris University Hospitals.

Learn more about the heart disease-diabetes connection:

 

 

"Our results indicate that among those with diabetes and stable coronary artery disease, we should focus on ticagrelor for patients with a history of prior stenting. This is an easily identifiable, logical sub-group," said Bhatt. "Studies currently support using long-term dual antiplatelet therapy for patients with the acute coronary syndrome who are at high ischemic risk but low bleeding risk. Our work suggests that a much broader population of patients with stable coronary artery disease and diabetes stand to benefit substantially."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 19, 2020
Drug Discovery & Development
Synapse-Saving Proteins Could Stave Off Alzheimer's
JUL 19, 2020
Synapse-Saving Proteins Could Stave Off Alzheimer's
Researchers at the University of Texas have identified a new subset of proteins capable of protecting synapses- the stru ...
JUL 21, 2020
Health & Medicine
FDA Produces Draft Guidelines on Developing Cannabis Drugs
JUL 21, 2020
FDA Produces Draft Guidelines on Developing Cannabis Drugs
The FDA’s Center for Drug Evaluation and Research has produced guidelines for research into cannabis-related ingre ...
JUL 14, 2020
Drug Discovery & Development
Less Addictive Opioid
JUL 14, 2020
Less Addictive Opioid
Opioids continue to have a bad name, and for a good reason, the number of lives they took due to their abuse has led to ...
JUL 29, 2020
Cancer
Regulating Apoptosis in Prostate Cancer
JUL 29, 2020
Regulating Apoptosis in Prostate Cancer
Cancer treatments tend to work in one of a few ways. They can target the immune system, prevent cancer proliferation and ...
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
JUL 31, 2020
Drug Discovery & Development
Researchers Reverse Advanced Alzheimer's in Mice
JUL 31, 2020
Researchers Reverse Advanced Alzheimer's in Mice
Researchers from Macquarie University have found a way to reverse the effects of memory loss in mice with advanced demen ...
Loading Comments...